Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Hepatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04102098
What this trial is testing

Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 668
Testing effectiveness (Phase 2)Study completedNCT00030563
What this trial is testing

Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
University of Washington
Not applicableActive Not RecruitingNCT06886763
What this trial is testing

HCC Innervation Assessment

Who this might be right for
Hepatocarcinoma
Hospices Civils de Lyon 300
Large-scale testing (Phase 3)Study completedNCT00760721
What this trial is testing

Increasing Hepatitis B Screening Among Korean Church Attendees

Who this might be right for
Hepatitis B
University of California, Los Angeles 1,123
Not applicableUnknownNCT03211598
What this trial is testing

Surefire Institutional DEB-TACE

Who this might be right for
Hepatocellular Carcinoma
Alexander Kim 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06253598
What this trial is testing

Efficacy and Safety of Intratumoral Injection of Recombinant Human Adenovirus Type 5 Combined With Tislelizumab and Lenvatinib in the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
The First Affiliated Hospital of Bengbu Medical University 30
Not applicableUnknownNCT03493763
What this trial is testing

Study on Recurrence Monitoring of Hepatocellular Carcinoma With 5-Hydroxymethylcytosine Test

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 300
Not applicableStudy completedNCT00820157
What this trial is testing

Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 120
Not applicableUnknownNCT03195075
What this trial is testing

Endoscopic Ultrasonography Guided Biliary Drainage

Who this might be right for
Malignant Hepatobiliary Neoplasm
Assiut University 40
Not applicableUnknownNCT06524557
What this trial is testing

Exploration of Noninvasive Differential Diagnosis of Benign and Malignant Liver Tumors

Who this might be right for
Liver Tumor
Xijing Hospital 200
Testing effectiveness (Phase 2)Study completedNCT04710641
What this trial is testing

Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone

Who this might be right for
Hepatocellular CarcinomaHepatitis BHepatitis C
Mina Alpha Limited 8
Not applicableUnknownNCT01957241
What this trial is testing

PLA for HCC and Esophageal ca Serum

Who this might be right for
Hepatocellular CarcinomaEsophageal Cancer
National Taiwan University Hospital 164
Not applicableLooking for participantsNCT06486454
What this trial is testing

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

Who this might be right for
Liver NeoplasmsPrimary Liver CancerSecondary Liver Cancer+2 more
HistoSonics, Inc. 5,000
Testing effectiveness (Phase 2)UnknownNCT03825705
What this trial is testing

A Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma

Who this might be right for
Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 60
Testing effectiveness (Phase 2)Ended earlyNCT01545141
What this trial is testing

Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaColorectal Tumors+1 more
Roswell Park Cancer Institute 15
Not applicableLooking for participantsNCT05713994
What this trial is testing

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Ze-yang Ding, MD 300
Early research (Phase 1)Study completedNCT02264886
What this trial is testing

Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal Malignancies

Who this might be right for
Central Thorax CancerLiver CancerNon-Liver Abdominal Cancer
Washington University School of Medicine 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07078305
What this trial is testing

Comparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line Treatment

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 134
Not applicableLooking for participantsNCT05661786
What this trial is testing

Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase

Who this might be right for
Chronic Hepatitis b
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 4,500
Testing effectiveness (Phase 2)Looking for participantsNCT07047586
What this trial is testing

Lenvatinib Plus Tislelizumab Versus Lenvatinib Alone in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab

Who this might be right for
Hepatocellular Carcinoma (HCC)
Fudan University 146
Next Page